Pronóstico del mercado de antiácidos de América del Sur y Central hasta 2027: impacto de COVID-19 y análisis regional por forma de dosificación (tableta, líquido y otros); Clase de fármaco (inhibidores de la bomba de protones, antagonista H2 y neutralizadores de ácido); Canal de Distribución (Farmacia Hospitalaria, Farmacia Minorista y Farmacia Online)
La clase de medicamentos que neutralizan el ácido del estómago se conocen como antiácidos. Se utiliza para tratar afecciones como acidez de estómago, indigestión, acidez y malestar estomacal. Estos medicamentos están disponibles sin receta y generalmente se consumen por vía oral. Están disponibles en tabletas, cápsulas, líquido y polvo. Hay diferentes tipos de antiácidos disponibles como hidróxido de aluminio, carbonato de magnesio, trisilicato de magnesio, hidróxido de magnesio, carbonato de calcio y bicarbonato de sodio.
Mercado Descripción general y dinámica
Se espera que el mercado de antiácidos de América del Sur y Central alcance los 792,18 millones de dólares en 2027 desde los 615,58 millones de dólares de 2019. Se estima que el mercado crecerá con una CAGR del 3,3% entre 2020 y 2027. Se estima que el crecimiento de este mercado crecerá debido a factores impulsores clave, como el aumento de la prevalencia de la enfermedad por reflujo gastroesofágico (ERGE) y un aumento de la prevalencia de la obesidad. Sin embargo, se espera que el mercado experimente un lento crecimiento durante el período previsto debido a la poca conciencia asociada con los trastornos gastrointestinales en las economías de bajos ingresos.
Segmentos clave del mercado
Según la forma de dosificación, el mercado de antiácidos se segmenta en tabletas, líquidos y otros. Según la clase de fármaco, el mercado de antiácidos se segmenta en inhibidores de la bomba de protones, antagonistas H2 y neutralizadores de ácido. Según el canal de distribución, el mercado de antiácidos se segmenta en farmacia hospitalaria, farmacia minorista y farmacia online.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias del mercado de antiácidos incluidas en el informe son Organización Mundial de la Salud (OMS), ‘Actualización sobre la epidemiología de la enfermedad por reflujo gastroesofágico: una revisión sistemática’ publicado en 2014, y otros.
Razones para comprar el informe
< ul type=\"disc\">
Comprender el panorama del mercado de antiácidos de América del Sur y Central e identificar los segmentos del mercado que tienen más probabilidades de garantizar un fuerte retorno
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de antiácidos
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de antiácidos de América del Sur y Central identificando los segmentos de mercado con más ventas probables prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de antiácidos
Obtener ingresos de mercado Pronóstico del mercado por varios segmentos de 2019 a 2027 en la región de América del Sur y Central
strong>
SEGMENTACIÓN DEL MERCADO DE ANTIÁCIDOS EN AMÉRICA DEL SUR Y CENTRO
Por forma farmacéutica< /p>
Tableta
Líquido
Otros
Por clase de medicamento< /p>
Inhibidores de la bomba de protones
Antagonista H2
Neutralizadores de ácido
Magaldrato
Sucralfato
Otros
< p>Por canal de distribución
Farmacia hospitalaria
Farmacia minorista
Farmacia online
p>
Por país
América del Sur y Central
Brasil
Argentina
Resto de América del Sur y Central
  ;
Perfiles de empresas
Bayer AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd
Sanofi
Boehringer Ingelheim International GmbH
Dr. Laboratorios Reddy
Pfizer Inc
Reckitt Benckiser Group Plc
Procter & Apuesta
South and Central America Antacids Strategic Insights
Strategic insights for South and Central America Antacids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
South and Central America Antacids Report Scope
Report Attribute
Details
Market size in 2019
US$ 615.58 Million
Market Size by 2027
US$ 792.18 Million
Global CAGR (2020 - 2027)
3.3%
Historical Data
2017-2018
Forecast period
2020-2027
Segments Covered
By Forma farmacéutica
comprimido
lÃquido
By Clase de fármaco
inhibidores de la bomba de protones
antagonistas H2
neutralizadores de ácido
By Canal de distribución
farmacia hospitalaria
farmacia minorista
farmacia en lÃnea
Regions and Countries Covered
América del Sur y Central
Brasil
Argentina
Resto de América del Sur y Central
Market leaders and key company profiles
Bayer AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd
Sanofi
Boehringer Ingelheim International GmbH
Dr. Reddys Laboratories
Pfizer Inc
Reckitt Benckiser Group Plc
Procter & Gamble
Get more information on this report
South and Central America Antacids Regional Insights
The regional scope of South and Central America Antacids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - South and Central America Antacids Market
Bayer AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd
Sanofi
Boehringer Ingelheim International GmbH
Dr. Reddy's Laboratories
Pfizer Inc
Reckitt Benckiser Group Plc
Procter & Gamble
Frequently Asked Questions
How big is the South and Central America Antacids Market?
The South and Central America Antacids Market is valued at US$ 615.58 Million in 2019, it is projected to reach US$ 792.18 Million by 2027.
What is the CAGR for South and Central America Antacids Market by (2020 - 2027)?
As per our report South and Central America Antacids Market, the market size is valued at US$ 615.58 Million in 2019, projecting it to reach US$ 792.18 Million by 2027. This translates to a CAGR of approximately 3.3% during the forecast period.
What segments are covered in this report?
The South and Central America Antacids Market report typically cover these key segments-
Forma farmacéutica (comprimido, líquido)
Clase de fármaco (inhibidores de la bomba de protones, antagonistas H2, neutralizadores de ácido)
Canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea)
What is the historic period, base year, and forecast period taken for South and Central America Antacids Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Antacids Market report:
Historic Period : 2017-2018
Base Year : 2019
Forecast Period : 2020-2027
Who are the major players in South and Central America Antacids Market?
The South and Central America Antacids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Bayer AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd
Sanofi
Boehringer Ingelheim International GmbH
Dr. Reddys Laboratories
Pfizer Inc
Reckitt Benckiser Group Plc
Procter & Gamble
Who should buy this report?
The South and Central America Antacids Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the South and Central America Antacids Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For South and Central America Antacids Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines